...
机译:小分子诱导的MDM2和MDMX二聚化激活p53途径
Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110;
Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110;
Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110;
Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110;
Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110;
Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110;
Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110;
Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110;
Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110;
Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110;
Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110;
Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110;
Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110;
Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110;
Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110;
机译:重组双靶MDM2 / MDMX抑制剂通过在野生型P53多药乳腺癌细胞中激活Tab1 / Tak1 / P38 Mapk途径反转多柔比蛋白抗性
机译:靶向Mdm2–MdmX E3复合物的RING域可激活白血病/淋巴瘤细胞中p53途径的凋亡臂
机译:DNA损伤诱导MdmX在丝氨酸367上的磷酸化通过靶向MdmX进行Mdm2依赖性降解激活p53。
机译:p14ARF和YY1肽在MDM2-p53介导的致癌途径中的作用:计算机视角
机译:与Mdm2复合的丝氨酸15磷酸化p53被抑制激活p53效应子途径。
机译:小分子诱导的MDM2和MDMX二聚化激活p53途径
机译:小分子诱导的MDM2和MDMX二聚体的P53途径激活